Beranda › Miastenia Gravis › Missouri
Uji klinis Miastenia Gravis di Missouri
7 studi untuk Miastenia Gravis mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- NextGen Precision Health, Columbia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06414954KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Missouri, Columbia
Menerima pesertaFase 2/3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06193889A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- UM Health Care - Neurology and Sleep Disorders Clinic, Columbia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT06456580Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07478172Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Columbia
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT04202341A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- University of Kansas Medical Center Research Institute, Inc., Kansas City
Menerima pesertaFase 1/2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT07250750Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Apr 2025 · NCT06064695Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.